STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results

Autor: Hopkin, Robert J., Ganesh, Jaya, Deegan, Patrick, Goker-Alpan, Ozlem, Bernat, John, Wilcox, William R., Pahl, Madeleine V., Whitley, Chester B., Hughes, Derralynn, Nicholls, Kathleen, Cao, Liching, Chen, Michael, Shiue, Lisa H., Bowden, Emma, Jaggumantri, Sravan, Passalacqua, Cristobal, Souberbielle, Bernard, Cockroft, Bettina M.
Zdroj: In Molecular Genetics and Metabolism February 2023 138(2)
Databáze: ScienceDirect